About JensonR+

JensonR+ is a technical consultancy with a simple mission; we aim to promote better health through simplifying the journey from innovation to the marketplace.

Learn more

Our Company

JensonR+ is a technical consultancy with a simple mission; we aim to promote better health through simplifying the journey from innovation to the marketplace.

We achieve this through offering wide-ranging services to cover the full product life-cycle, from concept through to launch and beyond.

Our specialist team is experienced in regulatory affairs, product development, quality assurance, drug safety, medical information, copy approval, project management, training and market access. We can provide support at all levels, from strategy through to administration, which allows us to tailor our services to meet your specific needs as your company moves from innovation and development to the market place.

JensonR+ was formed in 2011, through a joint venture with the regulatory consultancy, Dr Regenold GmbH. Our clients range from small innovators and entrepreneurs, through to Blue Chip corporations, and come from the human and veterinary pharmaceutical, cosmetics, foods, devices, herbals and legal industries.

After the referendum which resulted in the decision for the UK to leave the European Union, and with UK exit negotiations underway, it became apparent that there was a large degree of uncertainty of what the post Brexit regulatory landscape would look like. JensonR+ prides itself on being a professional and adaptable organisation, this ensures we deliver consistently high levels of service, support and successes. As part of our continuing commitment to all our clients, existing and new, in 2017 we announced the opening of our Ireland based office to ensure we can continue to provide our clients with our full service offering. We believe that this proactive attitude to Brexit will help protect your brands, equity and help you build strategic blueprints.

Meet the Team

Sarah Ware
Sarah Ware
Chief Executive Officer
Nicola Hardman
Nicola Hardman
Director
James Hall
James Hall
Director
Sue Gandy
Sue Gandy
QPPV & Pharmacovigilance Manager
Matthew Burton
Matthew Burton
Technical Manager
Shane Sankey
Shane Sankey
Finance Manager
Sue Lakeman
Sue Lakeman
Regulatory Manager
Neil Prideaux
Neil Prideaux
Regulatory Manager
Helen Seurin
Helen Seurin
dQPPV & Senior Pharmacovigilance Officer
Susan Child
Susan Child
Scientific Officer
Rebekah Gladstone
Rebekah Gladstone
Finance Officer
Joanne Lokes
Joanne Lokes
Senior Regulatory Officer
Lisa Courtier
Lisa Courtier
Pharmacovigilance Officer
Marilyn Brown
Marilyn Brown
Medical Information Officer
Melanie Joy
Melanie Joy
Senior Regulatory Officer
Rebecca Liversedge
Rebecca Liversedge
Quality Management System Officer
David Lough
David Lough
Pharmacovigilance Officer
Cathy Tyler
Cathy Tyler
Regulatory Officer
Lisa White
Lisa White
Regulatory Officer
Chloe Child
Chloe Child
Regulatory Officer
Jo Biederman
Jo Biederman
Administrative Officer

Consultants

Martin Knight
Formerly the CEO of JensonR+, one of our company founders, currently a Director and a Board member, Martin has a long history of drug development and provision of strategic advice.
Jutta Schnirring-Mayer
One of our Board members and an expert in business development, market access, portfolio-management, including due diligence and licensing, and product supply processes. Jutta is also the Managing Director of Dr. Regenold GmbH.
Dr Michael Schachter
A clinician and senior academic who tutors in clinical pharmacology, Mike provides expert support to our pharmacovigilance team.
Christine Morris
A highly experienced Qualified Person and Responsible Person who has worked closely with JensonR+ over a period of several years.
Zen Pawlak
Formerly the Chief Technical Officer at JensonR+, Zen continues his working relationship with us as one of our Qualified Persons.
Dr Murray Yule
A pharmaceutical physican with fifteen years’ experience of drug development and commercialisation.
Anthony Chapman
A quality assurance and product development specialist working for nine years within JensonR+, Anthony continues his working relationship with us as one of our Responsible Persons.
Linda Armstrong
A pharmaceutical marketer in the UK and Ireland with over 25 years’ experience in all aspects of marketing, Linda supports JensonR+ with product launch plans, including pricing and reimbursement, and in promotional compliance.

Regulanet

JensonR+ Limited is a lead member of the international regulatory network regulanet®

regulanet® is a group of highly skilled, experienced, like minded individuals and their companies, who have come together to offer a complete healthcare development service. Together, we form a network with representation in over 90 countries throughout the world. The services we offer span all aspects of product development, from brand and company strategy, product formulation and development, packaging development and implementation, extensive clinical, medical and regulatory expertise coupled with technology sourcing, product licensing and world class project management capabilities.

Founded in 2001 by Dr. Regenold GmbH, regulanet® offers services to a wide variety of national and international healthcare and pharmaceutical clients. The members of the network provide advice and assistance on national and international projects and marketing authorisation procedures, including the decentralised, mutual recognition and centralised procedures within Europe.

Our clients can utilise all of the resources that regulanet® can offer, or just access a specific part of our capabilities. Whatever your requirements, a project leader will provide a single point of contact and coordinate all project activity across the network.

Over the years the services offered by members have been expanded and now include all aspects of development, regulatory and market access in their respective countries.